Mdr Limited · SGX:Y3D
Mdr — Shareholder Meeting (June 2020)
23 slides from Mdr's shareholder meeting presentation, Jun 29, 2020
Slide 1: Annual General Meeting
Appendix A Annual General Meeting 29 June 2020
Slide 2: Financial Results: YoY Segmental Breakdown of Revenue (Continuing Operations)
Financial Results: YoY Segmental Breakdown of Revenue (Continuing Operations) ($’000) FY 2019 FY 2018 DMS 253,048 232,847 AMS 19,864 24,240 DPAS 5,793 6,153 INVESTMENT 6,986 1,629 Total 285,691 264,869 2
Slide 3: Financial Results: YoY Segmental Breakdown of Gross Profits (Continuing Operations)
Financial Results: YoY Segmental Breakdown of Gross Profits (Continuing Operations) ($’000) FY 2019 FY 2018 DMS 18,619 17,131 AMS 5,266 6,102 DPAS 1,684 1,900 INVESTMENT 6,986 1,629 Total 32,555 26,762 3
Slide 4: FY2019 Financial Highlights: Profit after Tax
FY2019 Financial Highlights: Profit after Tax Non‐cash impairments FY 2019 Profit after tax ($’000) ($’000) 4,500 Continuing Operations 4,000 Profit for the year 1,041 3,500 3,000 Impairment impact: 2,500 Impairment of right‐of‐use assets 571 4,218 2,000 Impairment of investment in debt 1,851 1,500
Slide 5: FY2019 Financial Highlights: EBITDA
FY2019 Financial Highlights: EBITDA EBITDA ($’000) 9,000 8,000 8,361 7,000 6,000 5,000 4,000 3,000 6,328 4,575 2,000 1,000 ‐ FY2017 FY2018 FY2019 Note: EBITDA for FY2019 includes approximately $4m arising from the adoption of SFRS(I) 16 Leases. 5
Slide 6: Investments: Performance Overview
Investments: Performance Overview ($’000) FY 2017 FY 2018 FY 2019 Investment performance (1,457) (2,705) 3,664 (inclusive of dividends from equity investment and accrued interest income from bond investment) ($’000) 1Q‐2019 2Q‐2019 3Q‐2019 4Q‐2019 Investment performance 4,110 (1,207) (4,750) 5,511 (
Slide 7: Dividend
Dividend 2500000 2000000 1500000 1000000 1,000,000 2,000,000 2,000,000 1,300,000 500000 1,000,000 500,000 0 2015 2016 2017 2018 2019 Interim Dividend Final Dividend 7
Slide 8: 2020 Outlook
2020 Outlook Investment division expected to be Group’s growth engine Barring any unforeseen event, Group committed to achieve better performance in FY2020 COVID‐19 outbreak and uncertainties in the global economy may exert pressure on the Group’s profit targets for FY2020 DMS division’s per
Slide 9: Questions from shareholders
Substantial and relevant questions Questions from shareholders 1. The current crisis provides opportunities for superior investment performance. Can management provide an update on the performance of its Investment division and also the broad investment strategies management intends to increase the
Slide 10: Substantial and relevant questions
Substantial and relevant questions 2. What are mDR's future plans/projects in 2021/2022? What is the vision of mDR in the next three to five years? The Group will continue to maintain the forward momentum to accelerate growth and create shareholder value and to improve its profitability, dividend an
Slide 11: Substantial and relevant questions
Substantial and relevant questions 4. Can we shareholders request for dividend, moving forth? The Company remains committed to achieving better performance and dividend payment to shareholders in the future. The Company declared an interim dividend of S$2 m (approximate) in 1H‐FY2019. As mentioned i
Slide 12: Substantial and relevant questions
Substantial and relevant questions 5. Will the price for each share be adjusted to S$0.01 after the proposed share consolidation? The 6‐months volume average weighted price of Company’s shares is S$0.001. Subject to shareholders’ approval, upon the completion of the proposed consolidation of every e
Slide 13: Substantial and relevant questions
Substantial and relevant questions 7. The trading volume of mDR remains low for a prolonged period of time. Besides share consolidation, is there any other avenue the Board is exploring? Trading volume is a function of matching willing buyers and willing sellers for any given price. More efficient p
Slide 14: Substantial and relevant questions
Substantial and relevant questions 9. What is the remuneration of the Executive Chairman linked to, especially with regards to his performance managing the investments? The policies and practices adopted by the Company in relation to remuneration, relationships between remuneration, performance and
Slide 15: Questions from SIAS
Substantial and relevant questions Questions from SIAS 10. Would the board/management provide shareholders with better clarity on the following operational/strategic matters? Specifically: (i) DMS: The group has a distribution management solutions (DMS) segment and which generated approximately $253
Slide 16: Substantial and relevant questions
Substantial and relevant questions (ii) Investments: The investment division is being viewed as the “future growth engine” of the group. Nearly $80 million raised from the Rights cum Warrants issue million has been deployed (as at 17 March 2020). The group has taken a “conservative balanced approach
Slide 17: Substantial and relevant questions
Substantial and relevant questions The Group has established a proper and robust risk management framework. A Risk Register is maintained, which: (a) identifies the risk areas that may be relevant to the Group; (b) assesses the extent of impact to, and vulnerability of, the Group, should such risks
Slide 18: Substantial and relevant questions
Substantial and relevant questions (iii) Performance: In Note 10c (page 123 – Investment in equity securities), it was disclosed that a net fair value decrease of $2,977,000 (2018: $4,018,000) was recorded for the year. In addition, in Note 10d (page 124 – Investment in debt securities), as at Decem
Slide 19: Share Buy-back
Substantial and relevant questions 11. Share Buy‐back (i) Can the company help shareholders understand if it had conducted the share buyback in accordance with the SGX rules? The Company has conducted the share buy‐back in accordance with the relevant SGX rules. (ii) Would the board, particularly th
Slide 20: Substantial and relevant questions
Substantial and relevant questions (iii) Would the board be reviewing the company’s share buy‐back practices (in price, volume and timing) to ensure that they are more in line with SGX rules? This would ensure that the company buys back shares in a responsible manner that does not artificially inter
Slide 21: Substantial and relevant questions
Substantial and relevant questions (ii) Were there specific agenda items or reasons to invite the executive directors to all the board committee meetings? There were no specific reasons to invite the executive directors to all the Board committee meetings. They attend the meetings together with the
Slide 22: Thank you
Thank you 22
Slide 23: Disclaimer
Disclaimer This presentation should be read in conjunction with the FY2019 audited Financial Statements of MDR Ltd (“MDR”, and together with its subsidiaries, the “Group”). The past performance of MDR is not necessarily indicative of its future performance. This presentation may contain forward‐look